Portfolio review

I took a day off work today to consolidate some of my investment portfolio matters. I went to the Suntec investment seminar on Sunday to listen to some seminars regarding portfolio building and bond investing, and consolidate the findings on Monday. 

Although I confess I am not into bond investment at the moment, with interest rates expected to rise all the way until next year, it is a rare chance to listen to professionals speak regarding this matter. Stocks may be overvalued as the economy picks up and I may have to research on picking bonds to supplement my portfolio. I will be also meeting my Philips capital adviser to consult him on portfolio matters as well as to meet up with my ex colleagues for lunch 

Taking a sombre view at my active picking results, I gather that value investing is bound to be vastly underperforming in the short run. I bought Hyflux, raffles medical, I trust and singtel within the span of this year, and upon getting notice of their 52 week low trading prices. In hindsight, Ocbc and Sti are also underperforming when I dollar cost averaged into them during June / July 2017 until Donald Trump got elected and janet yellen announced the reversal of quantitative easing. I am also aware that these stocks will need at least 2-3 years to materialise capital gain as they are highly dependent on turns out (hyflux), growth (raffles medical and I trust ).

After talking with the adviser and querying of some points, I realised that my position sizing and my market timing is very poor. For risky bets / turnabouts like Hyflux, my position should be MUCH lesser, and I can consider a combination of the 6% preference shares if my position is risky. Even if interest rates will erode the value of these preference shares, I can gain exposure to this company with a much less risk to my capital. Regardless, I got until 2019 to gauge if the company is able / unable to meet its long term financial obligations, as it will be forced to divest its assets, be so profitable (very unlikely) so that it can exercise its option to callback the preference share, or resort to cheaper finacing alternatives. This share still has 2 years to redeem itself, but averaging down is definitely too risky at the moment. For technical analysis, my entry points are lousy and I need to work on candlesticks charting to improve in it. 

Till then, I will complete my blog post about warren Buffet and John Templeton investment methodology. I might also take some time to screen through some low pe stocks. At least this weekend and today will be fruitful 





































































Comments

Post a Comment

Popular posts from this blog

A New Light

 A New Light After a hiatus from writing and picking myself up from the issues in my personal life, I decided it will be great to resume writing on a monthly frequency to connect with my inner self, and connect with like minded thinkers and writers.  Writing and investing is my passion regardless of whether I am getting paid for it. Even if no one is reading about it, writing keeps my mind sharp and discussions with others allows me to bounce off ideas with other experienced / astute investors. I am also thankful to have met new friends in person with a passion in investing in recent months, and reignite my passion in what I loved.  I will resume writing and blogging at https://caveatemptorvenditor.substack.com/
Read more

Michael Leong- Your first $1,000,000 Making it in stocks

Image
 Michael Leong- Local Legend After exhausting significant part of my war chest, I was very fortunate to chance upon the book published by a Local Legend - Dr Michael Leong. It was my second time rereading the book and the experiences he shared still felt as vivid as ever.  I first heard of Dr Michael Leong on Hyom Hyom blog whereby ML won significant praise as a wise and selfless investor which is willing to teach and share about his journey and the lessons he learnt. Dr Wealth also had a short writeup on him. The forums are now defunct and I was under the impression that his teachings had been lost. What I did not realize then is that ML also published a book. I rapidly snapped up this secret manual upon sighting his name in the library shelf. His insight into investing in Singapore is profound and sometimes contradictory, rational yet contrarian and well rooted in the context of Singapore Market. ML has a remarkable mind and strong self control, being able to clearly segreg
Read more

Portfolio Review 2019 - Performance Review

Image
Quantitative Measures Beta = 0.76, VaR = 8.92%, Expected Shortfall = 17.43% Overall - Time = 19.99% Performance Review for 2019 Beating the STI ETF benchmark is not difficult this year. As a market capitalized ETF, STI ETF was a late buyer in the REIT rally, which highlighted the downside of this methodology. Moreover, a lot of retail investors with larger proportion to REITS performed way better than me. My returns were also punished as I averaged down on Silverlake Axis on the recent price correction. I also sold off a percentage of STI ETF to increase my war chest instead of reallocating to US Stocks, resulting in the missing out of the Christmas rally and the year end momentum play. The S and P 500 trounced the returns of most market participants. I am not certain whether the blind money / DCA via index investors resulted into this phenomenon. There is significantly high PE stocks in the index constituents. Stocks could be simply getting more
Read more